Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behring Institute Mitteilungen

Showing results (31-40 of 617) with videos related to

Pageof 62
Sort By:
Behring Institute Mitteilungen|February 1, 1997
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cellsM Svensson, J Pfeifer, B Stockinger, et al.
Behring Institute Mitteilungen|February 1, 1997
Vaccine strategies against Pseudomonas aeruginosa infection in the lungA W Cripps, M L Dunkley, R L Clancy, et al.
Behring Institute Mitteilungen|February 1, 1997
Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosaD P Speert, S Y Wong, M Macdonald, et al.
Behring Institute Mitteilungen|February 1, 1997
Potential of protein OprF of Pseudomonas in bivalent vaccinesR E Hancock, R Wong
Behring Institute Mitteilungen|February 1, 1997
The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in manB U von Specht, H C Lücking, B Blum, et al.
Behring Institute Mitteilungen|February 1, 1997
Characterization of monoclonal antibodies to Pseudomonas aeruginosa type A flagellar antigenT C Montie, D Phillips, W J Landsperger
Behring Institute Mitteilungen|February 1, 1997
Helper T subsets and cytokines for mucosal immunity and toleranceJ L Vancott, M Kweon, K Fujihashi, et al.
Behring Institute Mitteilungen|February 1, 1997
Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogensI Steinmetz
Behring Institute Mitteilungen|February 1, 1997
Lymphocyte migration: an essential step in understanding the effects of vaccinationR Pabst, H J Rothkötter
Behring Institute Mitteilungen|February 1, 1997
Microbial heat shock proteins as vaccineA Noll, N Bücheler, E Bohn, et al.
Pageof 62

Showing results (31-40 of 617) with videos related to

Sort By:
Pageof 62
Behring Institute Mitteilungen|February 1, 1997
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cellsM Svensson, J Pfeifer, B Stockinger, et al.
Behring Institute Mitteilungen|February 1, 1997
Vaccine strategies against Pseudomonas aeruginosa infection in the lungA W Cripps, M L Dunkley, R L Clancy, et al.
Behring Institute Mitteilungen|February 1, 1997
Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosaD P Speert, S Y Wong, M Macdonald, et al.
Behring Institute Mitteilungen|February 1, 1997
Potential of protein OprF of Pseudomonas in bivalent vaccinesR E Hancock, R Wong
Behring Institute Mitteilungen|February 1, 1997
The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in manB U von Specht, H C Lücking, B Blum, et al.
Behring Institute Mitteilungen|February 1, 1997
Characterization of monoclonal antibodies to Pseudomonas aeruginosa type A flagellar antigenT C Montie, D Phillips, W J Landsperger
Behring Institute Mitteilungen|February 1, 1997
Helper T subsets and cytokines for mucosal immunity and toleranceJ L Vancott, M Kweon, K Fujihashi, et al.
Behring Institute Mitteilungen|February 1, 1997
Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogensI Steinmetz
Behring Institute Mitteilungen|February 1, 1997
Lymphocyte migration: an essential step in understanding the effects of vaccinationR Pabst, H J Rothkötter
Behring Institute Mitteilungen|February 1, 1997
Microbial heat shock proteins as vaccineA Noll, N Bücheler, E Bohn, et al.
Pageof 62